Summit Trail Advisors’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$785K Sell
37,928
-2,855
-7% -$67.3K 0.01% 1074
2026
Q1
$928K Buy
40,783
+16,267
+66% +$385K 0.01% 967
2025
Q4
$653K Sell
24,516
-8,032
-25% -$237K 0.01% 1004
2025
Q3
$988K Buy
32,548
+17,698
+119% +$537K 0.01% 841
2025
Q2
$466K Buy
+14,850
New +$491K 0.01% 757
2018
Q1
Sell
-81
Closed -$6K 796
2017
Q4
$6K Buy
+81
New +$5.45K ﹤0.01% 1356

Other funds holding ENOV

Summit Trail Advisors's ENOV Position: Q2 2026 in Review

Summit Trail Advisors reduced its Enovis (ENOV) stake by 7% in Q2 2026, selling an estimated $67.3K and leaving 37,928 shares worth $785K. The position accounts for 0.01% of the portfolio, ranked #1074.

Summit Trail Advisors first reported a position in ENOV in Q4 2017 and has held it in 6 quarters since. The position peaked at $988K in Q3 2025. 254 funds tracked by Wall St. Rank hold ENOV as of Q2 2026.

  • Summit Trail Advisors held 37,928 shares of Enovis worth $785K as of Q2 2026.
  • Summit Trail Advisors sold 2,855 Enovis shares in Q2 2026, an estimated $67.3K.
  • Enovis made up 0.01% of Summit Trail Advisors's portfolio in Q2 2026, its #1074 holding.
  • Summit Trail Advisors first reported a position in Enovis in Q4 2017 and has held it in 6 quarters since.
  • Summit Trail Advisors's Enovis position peaked at $988K in Q3 2025.
  • 254 funds tracked by Wall St. Rank held Enovis as of Q2 2026.

Based on Summit Trail Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.